[1] PELLETIER J P R,TRANSUE S,SNYDER E L. Pathogen inactivation techniques[J].Best Pract Res Clin Haematol,2006,19(1):205-242.
[2] FADDY H M,FRYK J J,HALL R A,et al.Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light[J]. Transfusion,2019,59(7):2223-2227.
[3] FRYK J J,MARKS D C,HOBSON-PETERS J,et al.Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light[J]. Transfusion,2017,57(11):2677-2682.
[4] MOHR H.Methylene blue and thionine in pathogen inactivation of plasma and platelet concentrates[J]. Transfus Apher Sci,2001,25(3):183-184.
[5] CICCHETTI A,BERRINO A,CASINI M,et al.Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use[J]. Blood Transfus,2016,14(4):287-386.
[6] IRSCH J,LIN L.Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT blood system™[J].Transfus Med Hemother,2011,38(1):19-31.
[7] LIN L,DIKEMAN R,MOLINI B,et al.Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria[J]. Transfusion,2004,44(10):1496-1504.
[8] LANTERI M C,SANTA-MARIA F,LAUGHHUNN A,et al.Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light[J]. Transfusion,2020,60(6):1319-1331.
[9] GIRARD Y A,SANTA MARIA F,LANTERI M C.Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen-reduction technology[J]. Transfusion,2020,60(3):622-627.
[10] CASTRO G,MERKEL P A,GICLAS H E,et al.Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease[J]. Transfusion,2018,58(6):1506-1515.
[11] MUNDT J M,ROUSE L,VAN DEN BOSSCHE J,et al. Chemical and biological mechanisms of pathogen reduction technologies[J].Photochem Photobiol,2014,90(5):957-964.
[12] JOSHI P C.Comparison of the DNA-damaging property of photosensitised riboflavin via singlet oxygen (1O2) and superoxide radical O2-. mechanisms[J].Toxicol Lett,1985,26(2/3):211-217.
[13] BELLO-LÓPEZ J M,DELGADO-BALBUENA L,ROJAS-HUIDOBRO D,et al. Treatment of platelet concentrates and plasma with riboflavin and UV light:impact in bacterial reduction[J]. Transfus Clin Biol,2018,25(3):197-203.
[14] SMITH J,ROCK G.Protein quality in Mirasol pathogen reduction technology-treated,apheresis-derived fresh-frozen plasma[J]. Transfusion,2010,50(4):926-931.
[15] QADRI S M,CHEN D,SCHUBERT P,et al.Pathogen inactivation by riboflavin and ultraviolet light illumination accelerates the red blood cell storage lesion and promotes eryptosis[J]. Transfusion,2017,57(3):661-673.
[16] WANG Y C,REN K,LIAO X Z,et al.Inactivation of Zika virus in plasma and derivatives by four different methods[J]. J Med Virol,2019,91(12):2059-2065.
[17] GARRAUD O,MALOT S,HERBRECHT R,et al.Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic Purpura[J]. Transfus Apher Sci,2019,58(6):102665.
[18] LEE L J,ROLAND K J,SREENIVASAN G M,et al.Solvent-detergent plasma for the treatment of thrombotic microangiopathies:a Canadian tertiary care centre experience[J]. Transfus Apher Sci,2018,57(2):233-235.
[19] ROCK G.A comparison of methods of pathogen inactivation of FFP[J].Vox Sang,2011,100(2):169-178.
[20] MOHR H,STEIL L,GRAVEMANN U,et al.A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light[J]. Transfusion,2009,49(12):2612-2624.
[21] RUSTANTI L,HOBSON-PETERS J,COLMANT A M G,et al. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light[J]. Transfusion,2020,60(11):2655-2660.
[22] PRADITYA D,FRIESLAND M,GRAVEMANN U,et al.Hepatitis E virus is effectively inactivated in platelet concentrates by ultraviolet C light[J]. Vox Sang,2020,115(7):555-561.
[23] SELTSAM A,MÜLLER T H. UVC irradiation for pathogen reduction of platelet concentrates and plasma[J]. Transfus Med Hemother,2011,38(1):43-54.
[24] CORASH L.Helinx technology for inactivation of infectious pathogens and leukocytes in labile blood components:from theory to clinical application[J]. Transfus Apher Sci,2001,25(3):179-181.
[25] CANCELAS J A,GOTTSCHALL J L,RUGG N,et al.Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability:results of a two-centre study[J]. Vox Sang,2017,112(3):210-218.
[26] BRIXNER V,KIESSLING A H,MADLENER K,et al.Red blood cells treated with the amustaline (S-303) pathogen reduction system:a transfusion study in cardiac surgery[J]. Transfusion,2018,58(4):905-916.
[27] NORTH A K,MUFTI N,SULLIVAN T,et al.Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione[J]. Transfusion,2020,60(2):358-366.
[28] COUTINHO N M,SILVEIRA M R,ROCHA R S,et al.Cold plasma processing of milk and dairy products[J]. Trends Food Sci Technol,2018,74:56-68.
[29] ŠIMONČICOVÁ J,KRYŠTOFOVÁ S,MEDVECKÁ V,et al. Technical applications of plasma treatments:current state and perspectives[J]. Appl Microbiol Biotechnol,2019,103(13):5117-5129.
[30] FILIPIĆ A,GUTIERREZ-AGUIRRE I,PRIMC G,et al.Cold plasma,a new hope in the field of virus inactivation[J]. Trends Biotechnol,2020,38(11):1278-1291.
[31] LIAO X Y,MUHAMMAD A I,CHEN S G,et al.Bacterial spore inactivation induced by cold plasma[J]. Crit Rev Food Sci Nutr,2019,59(16):2562-2572.
[32] ZHAO Y M,OJHA S,BURGESS C M,et al.Inactivation efficacy and mechanisms of plasma activated water on bacteria in planktonic state[J]. J Appl Microbiol,2020,129(5):1248-1260.
[33] BOURKE P,ZIUZINA D,HAN L,et al.Microbiological interactions with cold plasma[J]. J Appl Microbiol,2017,123(2):308-324.
[34] GUO L,XU R B,GOU L,et al.Mechanism of virus inactivation by cold atmospheric-pressure plasma and plasma-activated water[J]. Appl Environ Microbiol,2018,84(17):e00726-e00718.
[35] CHAROUX C M G,PATANGE A,LAMBA S,et al. Applications of nonthermal plasma technology on safety and quality of dried food ingredients[J]. J Appl Microbiol,2021,130(2):325-340.
[36] YADAV B,SPINELLI A C,GOVINDAN B N,et al.Cold plasma treatment of ready-to-eat ham:influence of process conditions and storage on inactivation of Listeria innocua[J]. Food Res Int,2019,123:276-285.
[37] YAN Y X,GAMBLE E B,NELSON K A.Impulsive stimulated scattering:general importance in femtosecond laser pulse interactions with matter,and spectroscopic applications[J]. J Chem Phys,1985,83(11):5391-5399.
[38] TSEN S W D,WU T C,KIANG J G,et al. Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation[J]. J Biomed Sci,2012,19(1):62.
[39] TSEN S W D,KINGSLEY D H,KIBLER K,et al. Pathogen reduction in human plasma using an ultrashort pulsed laser[J]. PLoS One,2014,9(11):e111673.
[40] GASPAR L P,SILVA A C B,GOMES A M O,et al. Hydrostatic pressure induces the fusion-active state of enveloped viruses[J]. J Biol Chem,2002,277(10):8433-8439.
[41] ARAUD E,DICAPRIO E,YANG Z H,et al.High-pressure inactivation of rotaviruses:role of treatment temperature and strain diversity in virus inactivation[J]. Appl Environ Microbiol,2015,81(19):6669-6678.
[42] GAYÁN E,GOVERS S K,AERTSEN A. Impact of high hydrostatic pressure on bacterial proteostasis[J]. Biophys Chem,2017,231:3-9.
[43] DARS A G,HU K,LIU Q D,et al.Effect of thermo-sonication and ultra-high pressure on the quality and phenolic profile of mango juice[J]. Foods,2019,8(8):298.
[44] NAKAGAMI T,OHNO H,SHIGEHISA T,et al.Inactivation of human immunodeficiency virus by high hydrostatic pressure[J]. Transfusion,1996,36(5):475-476.
[45] YANG C H,BIAN G H,YANG H,et al.Development of high hydrostatic pressure applied in pathogen inactivation for plasma[J]. PLoS One,2016,11(8):e0161775.
[46] RIVALAIN N,ROQUAIN J,BOIRON J M,et al.High hydrostatic pressure treatment for the inactivation of Staphylococcus aureus in human blood plasma[J]. N Biotechnol,2012,29(3):409-414.
[47] BRADLEY D W,HESS R A,TAO F,et al.Pressure cycling technology:a novel approach to virus inactivation in plasma[J]. Transfusion,2000,40(2):193-200.
[48] EICKMANN M,GRAVEMANN U,HANDKE W,et al.Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light,respectively[J]. Transfusion,2018,58(9):2202-2207.
[49] FADDY H M,FRYK J J,WATTERSON D,et al.Riboflavin and ultraviolet light:impact on dengue virus infectivity[J]. Vox Sang,2016,111(3):235-241.
[50] RAGAN I,HARTSON L,PIDCOKE H,et al.Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light[J]. PLoS One,2020,15(5):e0233947. |
